Report Cover

Global Acute Migraine Drugs Market Insights and Forecast to 2027


Acute Migraine Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Acute Migraine Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
    Triptans
    NSAIDs
    Others
    The proportion of triptans in 2019 is about 79.59% market share.

Segment by Application
    Hospital Pharmacies
    Drug Stores
    The proportion of hospitals in 2019 is about 62.93%.

By Company
    GSK
    Teva
    Pfizer
    Novartis
    Sun Pharma
    Grunenthal
    Endo Pharmaceuticals
    Merck
    J & J

By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
1 Study Coverage
    1.1 Acute Migraine Drugs Product Introduction
    1.2 Market by Type
        1.2.1 Global Acute Migraine Drugs Market Size Growth Rate by Type
        1.4.2 Triptans
        1.4.3 NSAIDs
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Acute Migraine Drugs Market Size Growth Rate by Application
        1.3.2 Hospital Pharmacies
        1.3.3 Drug Stores
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
    2.1 Global Acute Migraine Drugs Sales Estimates and Forecasts 2016-2027
    2.2 Global Acute Migraine Drugs Revenue Estimates and Forecasts 2016-2027
    2.3 Global Acute Migraine Drugs Revenue by Region: 2016 VS 2021 VS 2027
    2.4 Global Top Acute Migraine Drugs Regions by Sales
        2.4.1 Global Top Acute Migraine Drugs Regions by Sales (2016-2021)
        2.4.2 Global Top Acute Migraine Drugs Regions by Sales (2022-2027)
    2.5 Global Top Acute Migraine Drugs Regions by Revenue
        2.5.1 Global Top Acute Migraine Drugs Regions by Revenue (2016-2021)
        2.5.2 Global Top Acute Migraine Drugs Regions by Revenue (2022-2027)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Acute Migraine Drugs Sales by Manufacturers
        3.1.1 Global Top Acute Migraine Drugs Manufacturers by Sales (2016-2021)
        3.1.2 Global Top Acute Migraine Drugs Manufacturers Market Share by Sales (2016-2021)
        3.1.3 Global Top 10 and Top 5 Companies by Acute Migraine Drugs Sales in 2020
    3.2 Global Acute Migraine Drugs Revenue by Manufacturers
        3.2.1 Global Top Acute Migraine Drugs Manufacturers by Revenue (2016-2021)
        3.2.2 Global Top Acute Migraine Drugs Manufacturers Market Share by Revenue (2016-2021)
        3.2.3 Global Top 10 and Top 5 Companies by Acute Migraine Drugs Revenue in 2020
    3.3 Global Acute Migraine Drugs Sales Price by Manufacturers
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Acute Migraine Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Acute Migraine Drugs Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
    4.1 Global Acute Migraine Drugs Sales by Type
        4.1.1 Global Acute Migraine Drugs Historical Sales by Type (2016-2021)
        4.1.2 Global Acute Migraine Drugs Forecasted Sales by Type (2022-2027)
        4.1.3 Global Acute Migraine Drugs Sales Market Share by Type (2016-2027)
    4.2 Global Acute Migraine Drugs Revenue by Type
        4.2.1 Global Acute Migraine Drugs Historical Revenue by Type (2016-2021)
        4.2.2 Global Acute Migraine Drugs Forecasted Revenue by Type (2022-2027)
        4.2.3 Global Acute Migraine Drugs Revenue Market Share by Type (2016-2027)
    4.3 Global Acute Migraine Drugs Price by Type
        4.3.1 Global Acute Migraine Drugs Price by Type (2016-2021)
        4.3.2 Global Acute Migraine Drugs Price Forecast by Type (2022-2027)
5 Market Size by Application
    5.1 Global Acute Migraine Drugs Sales by Application
        5.1.1 Global Acute Migraine Drugs Historical Sales by Application (2016-2021)
        5.1.2 Global Acute Migraine Drugs Forecasted Sales by Application (2022-2027)
        5.1.3 Global Acute Migraine Drugs Sales Market Share by Application (2016-2027)
    5.2 Global Acute Migraine Drugs Revenue by Application
        5.2.1 Global Acute Migraine Drugs Historical Revenue by Application (2016-2021)
        5.2.2 Global Acute Migraine Drugs Forecasted Revenue by Application (2022-2027)
        5.2.3 Global Acute Migraine Drugs Revenue Market Share by Application (2016-2027)
    5.3 Global Acute Migraine Drugs Price by Application
        5.3.1 Global Acute Migraine Drugs Price by Application (2016-2021)
        5.3.2 Global Acute Migraine Drugs Price Forecast by Application (2022-2027)

6 North America
    6.1 North America Acute Migraine Drugs Market Size by Type
        6.1.1 North America Acute Migraine Drugs Sales by Type (2016-2027)
        6.1.2 North America Acute Migraine Drugs Revenue by Type (2016-2027)
    6.2 North America Acute Migraine Drugs Market Size by Application
        6.2.1 North America Acute Migraine Drugs Sales by Application (2016-2027)
        6.2.2 North America Acute Migraine Drugs Revenue by Application (2016-2027)
    6.3 North America Acute Migraine Drugs Market Size by Country
        6.3.1 North America Acute Migraine Drugs Sales by Country (2016-2027)
        6.3.2 North America Acute Migraine Drugs Revenue by Country (2016-2027)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Acute Migraine Drugs Market Size by Type
        7.1.1 Europe Acute Migraine Drugs Sales by Type (2017-2027)
        7.1.2 Europe Acute Migraine Drugs Revenue by Type (2017-2027)
    7.2 Europe Acute Migraine Drugs Market Size by Application
        7.2.1 Europe Acute Migraine Drugs Sales by Application (2017-2027)
        7.2.2 Europe Acute Migraine Drugs Revenue by Application (2017-2027)
    7.3 Europe Acute Migraine Drugs Market Size by Country
        7.3.1 Europe Acute Migraine Drugs Sales by Country (2017-2027)
        7.3.2 Europe Acute Migraine Drugs Revenue by Country (2017-2027)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Acute Migraine Drugs Market Size by Type
        8.1.1 Asia Pacific Acute Migraine Drugs Sales by Type (2018-2027)
        8.1.2 Asia Pacific Acute Migraine Drugs Revenue by Type (2018-2027)
    8.2 Asia Pacific Acute Migraine Drugs Market Size by Application
        8.2.1 Asia Pacific Acute Migraine Drugs Sales by Application (2018-2027)
        8.2.2 Asia Pacific Acute Migraine Drugs Revenue by Application (2018-2027)
    8.3 Asia Pacific Acute Migraine Drugs Market Size by Region
        8.3.1 Asia Pacific Acute Migraine Drugs Sales by Region (2018-2027)
        8.3.2 Asia Pacific Acute Migraine Drugs Revenue by Region (2018-2027)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Acute Migraine Drugs Market Size by Type
        9.1.1 Latin America Acute Migraine Drugs Sales by Type (2019-2027)
        9.1.2 Latin America Acute Migraine Drugs Revenue by Type (2019-2027)
    9.2 Latin America Acute Migraine Drugs Market Size by Application
        9.2.1 Latin America Acute Migraine Drugs Sales by Application (2019-2027)
        9.2.2 Latin America Acute Migraine Drugs Revenue by Application (2019-2027)
    9.3 Latin America Acute Migraine Drugs Market Size by Country
        9.3.1 Latin America Acute Migraine Drugs Sales by Country (2019-2027)
        9.3.2 Latin America Acute Migraine Drugs Revenue by Country (2019-2027)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
6 Middle East and Africa
    6.1 Middle East and Africa Acute Migraine Drugs Market Size by Type
        6.1.1 Middle East and Africa Acute Migraine Drugs Sales by Type (2016-2027)
        6.1.2 Middle East and Africa Acute Migraine Drugs Revenue by Type (2016-2027)
    6.2 Middle East and Africa Acute Migraine Drugs Market Size by Application
        6.2.1 Middle East and Africa Acute Migraine Drugs Sales by Application (2016-2027)
        6.2.2 Middle East and Africa Acute Migraine Drugs Revenue by Application (2016-2027)
    6.3 Middle East and Africa Acute Migraine Drugs Market Size by Country
        6.3.1 Middle East and Africa Acute Migraine Drugs Sales by Country (2016-2027)
        6.3.2 Middle East and Africa Acute Migraine Drugs Revenue by Country (2016-2027)
        6.3.3 Turkey
        6.3.4 Saudi Arabia
        6.3.5 U.A.E

11 Company Profiles
    11.1 GSK
        11.1.1 GSK Corporation Information
        11.1.2 GSK Overview
        11.1.3 GSK Acute Migraine Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
        11.1.4 GSK Acute Migraine Drugs Product Description
        11.1.5 GSK Related Developments
    11.2 Teva
        11.2.1 Teva Corporation Information
        11.2.2 Teva Overview
        11.2.3 Teva Acute Migraine Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
        11.2.4 Teva Acute Migraine Drugs Product Description
        11.2.5 Teva Related Developments
    11.3 Pfizer
        11.3.1 Pfizer Corporation Information
        11.3.2 Pfizer Overview
        11.3.3 Pfizer Acute Migraine Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
        11.3.4 Pfizer Acute Migraine Drugs Product Description
        11.3.5 Pfizer Related Developments
    11.4 Novartis
        11.4.1 Novartis Corporation Information
        11.4.2 Novartis Overview
        11.4.3 Novartis Acute Migraine Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
        11.4.4 Novartis Acute Migraine Drugs Product Description
        11.4.5 Novartis Related Developments
    11.5 Sun Pharma
        11.5.1 Sun Pharma Corporation Information
        11.5.2 Sun Pharma Overview
        11.5.3 Sun Pharma Acute Migraine Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
        11.5.4 Sun Pharma Acute Migraine Drugs Product Description
        11.5.5 Sun Pharma Related Developments
    11.6 Grunenthal
        11.6.1 Grunenthal Corporation Information
        11.6.2 Grunenthal Overview
        11.6.3 Grunenthal Acute Migraine Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
        11.6.4 Grunenthal Acute Migraine Drugs Product Description
        11.6.5 Grunenthal Related Developments
    11.7 Endo Pharmaceuticals
        11.7.1 Endo Pharmaceuticals Corporation Information
        11.7.2 Endo Pharmaceuticals Overview
        11.7.3 Endo Pharmaceuticals Acute Migraine Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
        11.7.4 Endo Pharmaceuticals Acute Migraine Drugs Product Description
        11.7.5 Endo Pharmaceuticals Related Developments
    11.8 Merck
        11.8.1 Merck Corporation Information
        11.8.2 Merck Overview
        11.8.3 Merck Acute Migraine Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
        11.8.4 Merck Acute Migraine Drugs Product Description
        11.8.5 Merck Related Developments
    11.9 J & J
        11.9.1 J & J Corporation Information
        11.9.2 J & J Overview
        11.9.3 J & J Acute Migraine Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
        11.9.4 J & J Acute Migraine Drugs Product Description
        11.9.5 J & J Related Developments
    11.1 GSK
        11.1.1 GSK Corporation Information
        11.1.2 GSK Overview
        11.1.3 GSK Acute Migraine Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
        11.1.4 GSK Acute Migraine Drugs Product Description
        11.1.5 GSK Related Developments

12 Value Chain and Sales Channels Analysis
    12.1 Acute Migraine Drugs Value Chain Analysis
    12.2 Acute Migraine Drugs Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Acute Migraine Drugs Production Mode & Process
    12.4 Acute Migraine Drugs Sales and Marketing
        12.4.1 Acute Migraine Drugs Sales Channels
        12.4.2 Acute Migraine Drugs Distributors
    12.5 Acute Migraine Drugs Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Acute Migraine Drugs Industry Trends
    13.2 Acute Migraine Drugs Market Drivers
    13.3 Acute Migraine Drugs Market Challenges
    13.4 Acute Migraine Drugs Market Restraints

14 Key Findings in The Global Acute Migraine Drugs Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables Table 1. Global Acute Migraine Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Triptans Table 3. Major Manufacturers of NSAIDs Table 4. Major Manufacturers of Others Table 5. Global Acute Migraine Drugs Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million) Table 6. Global Acute Migraine Drugs Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million) Table 7. Global Acute Migraine Drugs Sales by Region (2016-2021) & (K Unit) Table 8. Global Acute Migraine Drugs Sales Market Share by Region (2016-2021) Table 9. Global Acute Migraine Drugs Sales by Region (2016-2021) & (K Unit) Table 10. Global Acute Migraine Drugs Sales Market Share by Region (2022-2027) Table 11. Global Acute Migraine Drugs Revenue by Region (2016-2021) & (US$ Million) Table 12. Global Acute Migraine Drugs Revenue Market Share by Region (2016-2021) Table 13. Global Acute Migraine Drugs Revenue by Region (2022-2027) & (US$ Million) Table 14. Global Acute Migraine Drugs Revenue Market Share by Region (2022-2027) Table 15. Global Acute Migraine Drugs Sales by Manufacturers (2016-2021) & (K Unit) Table 16. Global Acute Migraine Drugs Sales Share by Manufacturers (2016-2021) Table 17. Global Acute Migraine Drugs Revenue by Manufacturers (2016-2021) & (US$ Million) Table 18. Global Acute Migraine Drugs Revenue Share by Manufacturers (2016-2021) Table 19. Acute Migraine Drugs Price by Manufacturers 2016-2021 (USD/Unit) Table 20. Global Acute Migraine Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table 21. Global Acute Migraine Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Migraine Drugs as of 2020) Table 22. Acute Migraine Drugs Manufacturing Base Distribution and Headquarters Table 23. Manufacturers Acute Migraine Drugs Product Offered Table 24. Date of Manufacturers Enter into Acute Migraine Drugs Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Acute Migraine Drugs Sales by Type (2016-2021) & (K Unit) Table 27. Global Acute Migraine Drugs Sales by Type (2022-2027) & (K Unit) Table 28. Global Acute Migraine Drugs Sales Share by Type (2016-2021) Table 29. Global Acute Migraine Drugs Sales Share by Type (2022-2027) Table 30. Global Acute Migraine Drugs Revenue by Type (2016-2021) & (US$ Million) Table 31. Global Acute Migraine Drugs Revenue by Type (2022-2027) & (US$ Million) Table 32. Global Acute Migraine Drugs Revenue Share by Type (2016-2021) Table 33. Global Acute Migraine Drugs Revenue Share by Type (2022-2027) Table 34. Acute Migraine Drugs Price by Type (2016-2021) & (USD/Unit) Table 35. Global Acute Migraine Drugs Price Forecast by Type (2022-2027) & (USD/Unit) Table 36. Global Acute Migraine Drugs Sales by Application (2016-2021) & (K Unit) Table 37. Global Acute Migraine Drugs Sales by Application (2022-2027) & (K Unit) Table 38. Global Acute Migraine Drugs Sales Share by Application (2016-2021) Table 39. Global Acute Migraine Drugs Sales Share by Application (2022-2027) Table 40. Global Acute Migraine Drugs Revenue by Application (2016-2021) & (US$ Million) Table 41. Global Acute Migraine Drugs Revenue by Application (2022-2027) & (US$ Million) Table 42. Global Acute Migraine Drugs Revenue Share by Application (2016-2021) Table 43. Global Acute Migraine Drugs Revenue Share by Application (2022-2027) Table 44. Acute Migraine Drugs Price by Application (2016-2021) & (USD/Unit) Table 45. Global Acute Migraine Drugs Price Forecast by Application (2022-2027) & (USD/Unit) Table 46. North America Acute Migraine Drugs Sales by Type (2016-2021) & (K Unit) Table 47. North America Acute Migraine Drugs Sales by Type (2022-2027) & (K Unit) Table 48. North America Acute Migraine Drugs Revenue by Type (2016-2021) & (US$ Million) Table 49. North America Acute Migraine Drugs Revenue by Type (2022-2027) & (US$ Million) Table 50. North America Acute Migraine Drugs Sales by Application (2016-2021) & (K Unit) Table 51. North America Acute Migraine Drugs Sales by Application (2022-2027) & (K Unit) Table 52. North America Acute Migraine Drugs Revenue by Application (2016-2021) & (US$ Million) Table 53. North America Acute Migraine Drugs Revenue by Application (2022-2027) & (US$ Million) Table 54. North America Acute Migraine Drugs Sales by Country (2016-2021) & (K Unit) Table 55. North America Acute Migraine Drugs Sales by Country (2022-2027) & (K Unit) Table 56. North America Acute Migraine Drugs Revenue by Country (2016-2021) & (US$ Million) Table 57. North America Acute Migraine Drugs Revenue by Country (2022-2027) & (US$ Million) Table 58. Europe Acute Migraine Drugs Sales by Type (2016-2021) & (K Unit) Table 59. Europe Acute Migraine Drugs Sales by Type (2022-2027) & (K Unit) Table 60. Europe Acute Migraine Drugs Revenue by Type (2016-2021) & (US$ Million) Table 61. Europe Acute Migraine Drugs Revenue by Type (2022-2027) & (US$ Million) Table 62. Europe Acute Migraine Drugs Sales by Application (2016-2021) & (K Unit) Table 63. Europe Acute Migraine Drugs Sales by Application (2022-2027) & (K Unit) Table 64. Europe Acute Migraine Drugs Revenue by Application (2016-2021) & (US$ Million) Table 65. Europe Acute Migraine Drugs Revenue by Application (2022-2027) & (US$ Million) Table 66. Europe Acute Migraine Drugs Sales by Country (2016-2021) & (K Unit) Table 67. Europe Acute Migraine Drugs Sales by Country (2022-2027) & (K Unit) Table 68. Europe Acute Migraine Drugs Revenue by Country (2016-2021) & (US$ Million) Table 69. Europe Acute Migraine Drugs Revenue by Country (2022-2027) & (US$ Million) Table 70. Asia Pacific Acute Migraine Drugs Sales by Type (2016-2021) & (K Unit) Table 71. Asia Pacific Acute Migraine Drugs Sales by Type (2022-2027) & (K Unit) Table 72. Asia Pacific Acute Migraine Drugs Revenue by Type (2016-2021) & (US$ Million) Table 73. Asia Pacific Acute Migraine Drugs Revenue by Type (2022-2027) & (US$ Million) Table 74. Asia Pacific Acute Migraine Drugs Sales by Application (2016-2021) & (K Unit) Table 75. Asia Pacific Acute Migraine Drugs Sales by Application (2022-2027) & (K Unit) Table 76. Asia Pacific Acute Migraine Drugs Revenue by Application (2016-2021) & (US$ Million) Table 77. Asia Pacific Acute Migraine Drugs Revenue by Application (2022-2027) & (US$ Million) Table 78. Asia Pacific Acute Migraine Drugs Sales by Region (2016-2021) & (K Unit) Table 79. Asia Pacific Acute Migraine Drugs Sales by Region (2022-2027) & (K Unit) Table 80. Asia Pacific Acute Migraine Drugs Revenue by Region (2016-2021) & (US$ Million) Table 81. Asia Pacific Acute Migraine Drugs Revenue by Region (2022-2027) & (US$ Million) Table 82. Latin America Acute Migraine Drugs Sales by Type (2016-2021) & (K Unit) Table 83. Latin America Acute Migraine Drugs Sales by Type (2022-2027) & (K Unit) Table 84. Latin America Acute Migraine Drugs Revenue by Type (2016-2021) & (US$ Million) Table 85. Latin America Acute Migraine Drugs Revenue by Type (2022-2027) & (US$ Million) Table 86. Latin America Acute Migraine Drugs Sales by Application (2016-2021) & (K Unit) Table 87. Latin America Acute Migraine Drugs Sales by Application (2022-2027) & (K Unit) Table 88. Latin America Acute Migraine Drugs Revenue by Application (2016-2021) & (US$ Million) Table 89. Latin America Acute Migraine Drugs Revenue by Application (2022-2027) & (US$ Million) Table 90. Latin America Acute Migraine Drugs Sales by Country (2016-2021) & (K Unit) Table 91. Latin America Acute Migraine Drugs Sales by Country (2022-2027) & (K Unit) Table 92. Latin America Acute Migraine Drugs Revenue by Country (2016-2021) & (US$ Million) Table 93. Latin America Acute Migraine Drugs Revenue by Country (2022-2027) & (US$ Million) Table 94. Middle East and Africa Acute Migraine Drugs Sales by Type (2016-2021) & (K Unit) Table 95. Middle East and Africa Acute Migraine Drugs Sales by Type (2022-2027) & (K Unit) Table 96. Middle East and Africa Acute Migraine Drugs Revenue by Type (2016-2021) & (US$ Million) Table 97. Middle East and Africa Acute Migraine Drugs Revenue by Type (2022-2027) & (US$ Million) Table 98. Middle East and Africa Acute Migraine Drugs Sales by Application (2016-2021) & (K Unit) Table 99. Middle East and Africa Acute Migraine Drugs Sales by Application (2022-2027) & (K Unit) Table 100. Middle East and Africa Acute Migraine Drugs Revenue by Application (2016-2021) & (US$ Million) Table 101. Middle East and Africa Acute Migraine Drugs Revenue by Application (2022-2027) & (US$ Million) Table 102. Middle East and Africa Acute Migraine Drugs Sales by Country (2016-2021) & (K Unit) Table 103. Middle East and Africa Acute Migraine Drugs Sales by Country (2022-2027) & (K Unit) Table 104. Middle East and Africa Acute Migraine Drugs Revenue by Country (2016-2021) & (US$ Million) Table 105. Middle East and Africa Acute Migraine Drugs Revenue by Country (2022-2027) & (US$ Million) Table 106. GSK Corporation Information Table 107. GSK Description and Major Businesses Table 108. GSK Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 109. GSK Acute Migraine Drugs Product Table 110. GSK Recent Developments Table 111. Teva Corporation Information Table 112. Teva Description and Major Businesses Table 113. Teva Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 114. Teva Acute Migraine Drugs Product Table 115. Teva Recent Developments Table 116. Pfizer Corporation Information Table 117. Pfizer Description and Major Businesses Table 118. Pfizer Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 119. Pfizer Acute Migraine Drugs Product Table 120. Pfizer Recent Developments Table 121. Novartis Corporation Information Table 122. Novartis Description and Major Businesses Table 123. Novartis Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 124. Novartis Acute Migraine Drugs Product Table 125. Novartis Recent Developments Table 126. Sun Pharma Corporation Information Table 127. Sun Pharma Description and Major Businesses Table 128. Sun Pharma Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 129. Sun Pharma Acute Migraine Drugs Product Table 130. Sun Pharma Recent Developments Table 131. Grunenthal Corporation Information Table 132. Grunenthal Description and Major Businesses Table 133. Grunenthal Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 134. Grunenthal Acute Migraine Drugs Product Table 135. Grunenthal Recent Developments Table 136. Endo Pharmaceuticals Corporation Information Table 137. Endo Pharmaceuticals Description and Major Businesses Table 138. Endo Pharmaceuticals Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 139. Endo Pharmaceuticals Acute Migraine Drugs Product Table 140. Endo Pharmaceuticals Recent Developments Table 141. Merck Corporation Information Table 142. Merck Description and Major Businesses Table 143. Merck Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 144. Merck Acute Migraine Drugs Product Table 145. Merck Recent Developments Table 146. J & J Corporation Information Table 147. J & J Description and Major Businesses Table 148. J & J Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 149. J & J Acute Migraine Drugs Product Table 150. J & J Recent Developments Table 151. Key Raw Materials Lists Table 152. Raw Materials Key Suppliers Lists Table 153. Acute Migraine Drugs Distributors List Table 154. Acute Migraine Drugs Customers List Table 155. Acute Migraine Drugs Market Trends Table 156. Acute Migraine Drugs Market Drivers Table 157. Acute Migraine Drugs Market Challenges Table 158. Acute Migraine Drugs Market Restraints Table 159. Research Programs/Design for This Report Table 160. Key Data Information from Secondary Sources Table 161. Key Data Information from Primary Sources List of Figures Figure 1. Acute Migraine Drugs Product Picture Figure 2. Global Acute Migraine Drugs Market Share by Type in 2020 & 2027 Figure 3. Triptans Product Picture Figure 4. NSAIDs Product Picture Figure 5. Others Product Picture Figure 6. Global Acute Migraine Drugs Sales Market Share by Application in 2020 & 2027 Figure 7. Hospital Pharmacies Figure 8. Drug Stores Figure 9. Acute Migraine Drugs Report Years Considered Figure 10. Global Acute Migraine Drugs Sales 2016-2027 (K Unit) Figure 11. Global Acute Migraine Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Acute Migraine Drugs Revenue 2016-2027 (US$ Million) Figure 13. Global Acute Migraine Drugs Revenue Market Share by Region in Percentage: 2020 Versus 2027 Figure 14. Global Acute Migraine Drugs Sales Market Share by Region (2016-2021) Figure 15. Global Acute Migraine Drugs Sales Market Share by Region (2022-2027) Figure 16. North America Acute Migraine Drugs Sales YoY (2016-2027) & (K Unit) Figure 17. North America Acute Migraine Drugs Revenue YoY (2016-2027) & (US$ Million) Figure 18. Europe Acute Migraine Drugs Sales YoY (2016-2027) & (K Unit) Figure 19. Europe Acute Migraine Drugs Revenue YoY (2016-2027) & (US$ Million) Figure 20. Asia-Pacific Acute Migraine Drugs Sales YoY (2016-2027) & (K Unit) Figure 21. Asia-Pacific Acute Migraine Drugs Revenue YoY (2016-2027) & (US$ Million) Figure 22. Latin America Acute Migraine Drugs Sales YoY (2016-2027) & (K Unit) Figure 23. Latin America Acute Migraine Drugs Revenue YoY (2016-2027) & (US$ Million) Figure 24. Middle East & Africa Acute Migraine Drugs Sales YoY (2016-2027) & (K Unit) Figure 25. Middle East & Africa Acute Migraine Drugs Revenue YoY (2016-2027) & (US$ Million) Figure 26. The Top 10 and Top 5 Players Market Share by Acute Migraine Drugs Sales in 2020 Figure 27. The Top 10 and Top 5 Players Market Share by Acute Migraine Drugs Revenue in 2020 Figure 28. Acute Migraine Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 29. Global Acute Migraine Drugs Sales Market Share by Type (2016-2027) Figure 30. Global Acute Migraine Drugs Revenue Market Share by Type (2016-2027) Figure 31. Global Acute Migraine Drugs Sales Market Share by Application (2016-2027) Figure 32. Global Acute Migraine Drugs Revenue Market Share by Application (2016-2027) Figure 33. North America Acute Migraine Drugs Sales Market Share by Type (2016-2027) Figure 34. North America Acute Migraine Drugs Revenue Market Share by Type (2016-2027) Figure 35. North America Acute Migraine Drugs Sales Market Share by Application (2016-2027) Figure 36. North America Acute Migraine Drugs Revenue Market Share by Application (2016-2027) Figure 37. North America Acute Migraine Drugs Sales Share by Country (2016-2027) Figure 38. North America Acute Migraine Drugs Revenue Share by Country (2016-2027) Figure 39. U.S. Acute Migraine Drugs Revenue (2016-2027) & (US$ Million) Figure 40. Canada Acute Migraine Drugs Revenue (2016-2027) & (US$ Million) Figure 41. Europe Acute Migraine Drugs Sales Market Share by Type (2016-2027) Figure 42. Europe Acute Migraine Drugs Revenue Market Share by Type (2016-2027) Figure 43. Europe Acute Migraine Drugs Sales Market Share by Application (2016-2027) Figure 44. Europe Acute Migraine Drugs Revenue Market Share by Application (2016-2027) Figure 45. Europe Acute Migraine Drugs Sales Share by Country (2016-2027) Figure 46. Europe Acute Migraine Drugs Revenue Share by Country (2016-2027) Figure 47. Germany Acute Migraine Drugs Revenue (2016-2027) & (US$ Million) Figure 48. France Acute Migraine Drugs Revenue (2016-2027) & (US$ Million) Figure 49. U.K. Acute Migraine Drugs Revenue (2016-2027) & (US$ Million) Figure 50. Italy Acute Migraine Drugs Revenue (2016-2027) & (US$ Million) Figure 51. Russia Acute Migraine Drugs Revenue (2016-2027) & (US$ Million) Figure 52. Asia Pacific Acute Migraine Drugs Sales Market Share by Type (2016-2027) Figure 53. Asia Pacific Acute Migraine Drugs Revenue Market Share by Type (2016-2027) Figure 54. Asia Pacific Acute Migraine Drugs Sales Market Share by Application (2016-2027) Figure 55. Asia Pacific Acute Migraine Drugs Revenue Market Share by Application (2016-2027) Figure 56. Asia Pacific Acute Migraine Drugs Sales Share by Region (2016-2027) Figure 57. Asia Pacific Acute Migraine Drugs Revenue Share by Region (2016-2027) Figure 58. China Acute Migraine Drugs Revenue (2016-2027) & (US$ Million) Figure 59. Japan Acute Migraine Drugs Revenue (2016-2027) & (US$ Million) Figure 60. South Korea Acute Migraine Drugs Revenue (2016-2027) & (US$ Million) Figure 61. India Acute Migraine Drugs Revenue (2016-2027) & (US$ Million) Figure 62. Australia Acute Migraine Drugs Revenue (2016-2027) & (US$ Million) Figure 63. Taiwan Acute Migraine Drugs Revenue (2016-2027) & (US$ Million) Figure 64. Indonesia Acute Migraine Drugs Revenue (2016-2027) & (US$ Million) Figure 65. Thailand Acute Migraine Drugs Revenue (2016-2027) & (US$ Million) Figure 66. Malaysia Acute Migraine Drugs Revenue (2016-2027) & (US$ Million) Figure 67. Philippines Acute Migraine Drugs Revenue (2016-2027) & (US$ Million) Figure 68. Latin America Acute Migraine Drugs Sales Market Share by Type (2016-2027) Figure 69. Latin America Acute Migraine Drugs Revenue Market Share by Type (2016-2027) Figure 70. Latin America Acute Migraine Drugs Sales Market Share by Application (2016-2027) Figure 71. Latin America Acute Migraine Drugs Revenue Market Share by Application (2016-2027) Figure 72. Latin America Acute Migraine Drugs Sales Share by Country (2016-2027) Figure 73. Latin America Acute Migraine Drugs Revenue Share by Country (2016-2027) Figure 74. Mexico Acute Migraine Drugs Revenue (2016-2027) & (US$ Million) Figure 75. Brazil Acute Migraine Drugs Revenue (2016-2027) & (US$ Million) Figure 76. Argentina Acute Migraine Drugs Revenue (2016-2027) & (US$ Million) Figure 77. Middle East and Africa Acute Migraine Drugs Sales Market Share by Type (2016-2027) Figure 78. Middle East and Africa Acute Migraine Drugs Revenue Market Share by Type (2016-2027) Figure 79. Middle East and Africa Acute Migraine Drugs Sales Market Share by Application (2016-2027) Figure 80. Middle East and Africa Acute Migraine Drugs Revenue Market Share by Application (2016-2027) Figure 81. Middle East and Africa Acute Migraine Drugs Sales Share by Country (2016-2027) Figure 82. Middle East and Africa Acute Migraine Drugs Revenue Share by Country (2016-2027) Figure 83. Turkey Acute Migraine Drugs Revenue (2016-2027) & (US$ Million) Figure 84. Saudi Arabia Acute Migraine Drugs Revenue (2016-2027) & (US$ Million) Figure 85. U.A.E Acute Migraine Drugs Revenue (2016-2027) & (US$ Million) Figure 86. Acute Migraine Drugs Value Chain Figure 87. Acute Migraine Drugs Production Process Figure 88. Channels of Distribution Figure 89. Distributors Profiles Figure 90. Bottom-up and Top-down Approaches for This Report Figure 91. Data Triangulation Figure 92. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us